Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-10-17

Clinical Trial Update: Expanded Access Program for Maraviroc At Multiple Centers [Phase 3]

View source ↗

Summary

Expanded Access Program for maraviroc in HIV infections across multiple centers has completed. Phase 3 results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Maraviroc (maraviroc)

Snippet

Sponsor: ViiV Healthcare | Conditions: HIV Infections | Phase 3 | Status: COMPLETED | Results posted: 2011-10-17